BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17241655)

  • 1. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of aspirin resistance.
    Patel D; Moonis M
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin resistance: effect of clinical, biochemical and genetic factors.
    Fitzgerald R; Pirmohamed M
    Pharmacol Ther; 2011 May; 130(2):213-25. PubMed ID: 21295071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance: focus on clinical endpoints.
    Pusch G; Feher G; Kotai K; Tibold A; Gasztonyi B; Feher A; Papp E; Lupkovics G; Szapary L
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):475-84. PubMed ID: 19034037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a definition of aspirin resistance: a typological approach.
    Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin resistance in stroke: 2004.
    Sztriha LK; Sas K; Vecsei L
    J Neurol Sci; 2005 Mar; 229-230():163-9. PubMed ID: 15760636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin resistance: what the cardiologist needs to know?
    Tousoulis D; Siasos G; Stefanadis C
    Int J Cardiol; 2009 Feb; 132(2):153-6. PubMed ID: 19167101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ; Kottke-Marchant K; Gorman RT
    Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
    Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
    Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part II: Potential causes and laboratory tests.
    Vadász D; Sztriha LK; Sas K; Vécsei L
    Ideggyogy Sz; 2013 Jan; 66(1-2):15-22. PubMed ID: 23607225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
    Cotter G; Shemesh E; Zehavi M; Dinur I; Rudnick A; Milo O; Vered Z; Krakover R; Kaluski E; Kornberg A
    Am Heart J; 2004 Feb; 147(2):293-300. PubMed ID: 14760328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the antiplatelet action of aspirin.
    Fritsma GA; Ens GE; Alvord MA; Carroll AA; Jensen R
    JAAPA; 2001 May; 14(5):57-8, 61-2. PubMed ID: 11523339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.